Is PATH a good stock to buy? We came across a bullish thesis on UiPath, Inc. on r/Valueinvesting by JamesSt-Patrick. In this article, we will summarize the bulls’ thesis on PATH. UiPath, Inc.’s share was trading at $12.13 as of March 23rd. PATH’s trailing and forward P/E were 23.19 and 14.53 respectively according to Yahoo Finance.
Copyright: rawpixel / 123RF Stock Photo
UiPath, Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States and internationally. PATH has evolved beyond its roots in robotic process automation (RPA) and is now positioning itself at the forefront of agentic AI, leveraging large language models from providers like Anthropic, OpenAI, and Google to build enterprise-grade AI agents.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
Unlike the narrative often promoted in developer communities, large enterprises—particularly Fortune 500 firms—cannot rely on internally built “vibe-coded” solutions due to liability, compliance, and scalability constraints. Instead, they are more likely to adopt trusted platforms like UiPath, which already serves roughly 60% of the Fortune 500, offering a significant distribution and trust advantage.
The company’s investment case is supported by a combination of operational scale, financial discipline, and strategic positioning. UiPath has achieved GAAP profitability, maintains zero interest-bearing debt, and generates approximately $1.8 billion in annual recurring revenue, supported by 16% year-over-year growth and eight consecutive quarters of ARR expansion.
With around $1.5 billion in cash and a forward P/E of ~15, the stock appears undervalued, particularly after a broader SaaS-driven selloff that has kept shares below $20 despite improving fundamentals. Institutional validation, including increased exposure from Point72 Asset Management, further reinforces confidence.
Structurally, demand for RPA remains strong, especially in regulated industries such as healthcare and financial services, where repetitive, rules-based processes require precision, auditability, and compliance. Rather than displacing RPA, AI is expected to increase its importance by expanding automation use cases. With its established infrastructure, extensive customer base, and LLM-agnostic strategy, UiPath is well-positioned to capitalize on the convergence of automation and AI, creating a compelling long-term opportunity.
Previously, we covered a bullish thesis on UiPath Inc. (PATH) by Alexandru Dragut in October 2024, which highlighted strong ARR growth, enterprise adoption, expanding AI-driven automation capabilities, and progress toward GAAP profitability. PATH’s stock price has depreciated by approximately 3.42% since our coverage. JamesSt-Patrick shares a similar view but emphasizes on UiPath’s shift toward agentic AI and rising enterprise demand for automation.
UiPath, Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 45 hedge fund portfolios held PATH at the end of the fourth quarter which was 48 in the previous quarter. While we acknowledge the risk and potential of PATH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PATH and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
